← All trials
NCT04959331
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 2, 2021
- Primary completion
- May 15, 2023
- Completion date
- May 30, 2023
- First posted
- Jul 13, 2021
- Last posted
- Jul 13, 2021
- Enrollment
- 1000
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Jordi Gol i Gurina FoundationLead sponsor
- Gerencia de Atención Primaria, MadridCollaborator
- Instituto de Investigación Sanitaria AragónCollaborator
- Balearic Islands Health Service (Ibsalut)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.